Dr. Morales is an accomplished biopharmaceutical executive who oversees all technical operations at Analgesic Solutions. In particular, Arturo leads the ongoing development and commercialization of the Company’s proprietary Quantitative Data Surveillance System (QDSS).
Upon completing his postdoctoral work with Dr. Paul Schimmel at Massachusetts Institute of Technology (MIT), Dr. Morales started his industry career with Genome Therapeutics as a Senior Computational Biologist. He subsequently led a variety of teams at various companies including the Novartis Institutes for Biomedical Research, where he was global lead for Biology Platform Informatics.
Dr. Morales is the founder of a digital health company that integrates traditional health metrics with a variety of data feeds in order to better identify trends and improve health outcomes.
Follow Arturo Morales, PhD on social media using the links below: